Nobel Prize 2026: How JNU scientist Suneel Kateriya helped lay the groundwork for optogenetics

What did the 2026 Nobel Prize in Physiology or Medicine recognize, and how did Suneel Kateriya's research contribute to it?

The 2026 Nobel Prize in Physiology or Medicine recognized Karl Deisseroth, Peter Hegemann and Georg Nagel for discovering light-gated ion channels and optogenetics. This work showed that light could control selected cells by changing their electrical activity. It transformed a basic biological question into a powerful research method.

Kateriya contributed an important foundation while working in Hegemann’s laboratory in Germany. In 2001, he searched Chlamydomonas genes and identified two light-sensing proteins. Their genes were later named channelrhodopsin-1 and channelrhodopsin-2. Later experiments showed that these proteins act as light-driven ion channels.

Kateriya was not seeking a way to control the human brain. His team wanted to learn how the alga sensed light. Their discoveries helped establish the molecular tools that optogenetics uses today. The technique now supports precise studies of neurons, memory and disease, although it remains mainly a research technology.

What is optogenetics, and how does it allow scientists to control selected cells with light?

Optogenetics is a technique for controlling specific cells with light. It matters because scientists can target particular neurons instead of affecting many cell types across a brain region. This gives researchers a clearer way to connect neural activity with behavior, memory and disease.

The method begins by introducing a gene for a light-sensitive protein into selected neurons. The protein combines a light sensor with an ion channel. When light reaches the engineered cell, the channel opens or changes the movement of ions. That shifts the cell’s electrical state and can switch the neuron on or influence its activity.

Optogenetics offers millisecond precision, matching the fast timescale of brain communication. It is already used widely in research and has entered early human work, including a retinal-vision trial. However, safe gene delivery, durable effects and precise targeting remain major challenges.

What did Kateriya discover in the single-celled alga Chlamydomonas?

In 2001, Suneel Kateriya studied Chlamydomonas, a single-celled freshwater alga that detects and moves toward light. Working in Peter Hegemann’s laboratory in Regensburg, Germany, he searched the alga’s genes for the machinery behind this behavior. His work addressed a basic question: how does this tiny organism sense light?

Kateriya identified two genes encoding light-sensing rhodopsin proteins. They were later named channelrhodopsin-1 and channelrhodopsin-2. Researchers proposed that the proteins might function as light-driven ion channels, rather than merely sensing light.

Experiments published in 2002 and 2003 showed that the proteins act as molecular gates. Light causes them to open and allows ions to move, changing a cell’s electrical activity. This discovery eventually provided tools for controlling neurons. It was not originally intended to study the human brain, but it became foundational to optogenetics.

How do channelrhodopsins act as light-controlled molecular gates that change a neuron's activity?

A channelrhodopsin combines two jobs in one protein. It senses light and forms a channel through a cell membrane. This matters because a light signal can be converted directly into an electrical change inside the cell.

When researchers introduce a channelrhodopsin gene into a neuron, the neuron begins producing the light-sensitive protein. Shining light on that neuron activates the protein. Its channel opens, allowing charged particles, called ions, to move across the membrane. The resulting change in electrical conditions can switch the neuron on or influence how it behaves.

This molecular action gives optogenetics its unusual precision. Scientists can choose cells carrying the gene and stimulate them with light at millisecond timescales. The method does not restore normal brain function automatically, and it requires suitable gene delivery and light access. Still, channelrhodopsins provide a direct bridge between light and neural activity.

How precise is optogenetic control compared with older methods of stimulating the brain?

Optogenetics is more precise than older methods because it can separate targeted neurons from neighboring cells. Earlier approaches could stimulate a broader brain region and affect multiple cell types together. That made it harder to identify which cells caused a particular response.

With optogenetics, researchers first place a light-sensitive protein in selected neurons. They then shine light on the relevant tissue. Only cells carrying the protein respond directly, and their activity can be changed rapidly. The article describes this control as occurring with pinpoint, millisecond precision, matching the speed of neural communication.

This precision helps scientists test cause and effect in brain circuits. They can ask what happens when one defined population of neurons is activated or influenced. The method is not yet equally practical everywhere in humans. Gene delivery, access for light and safe, durable control of exactly the right cells remain significant barriers.

What has optogenetics enabled scientists to learn about neural circuits, memory, vision and disease?

Optogenetics has made neural circuits easier to study because researchers can control defined cell populations and observe the results. This has strengthened investigations of how brain activity relates to behavior, memory and disease. It offers a more direct test than simply stimulating a large area.

In mice, optogenetic experiments linked specific neurons to learned fear responses. The technique has also advanced vision research. In a 2021 trial, a patient with retinitis pigmentosa received a gene for the channelrhodopsin ChrimsonR. Special goggles projected light onto the retina, and the patient could perceive, locate, count and touch objects with the treated eye.

The result was partial recovery in one patient, not normal sight. Researchers also use optogenetics in Indian laboratories to study vision, glioblastoma and genetic diseases. Its future depends on safer gene delivery, long-term control and practical light delivery, especially in the human brain.

How do neurons normally communicate through electrical signals and the movement of ions?

Neurons communicate through changes in electrical activity. Their membranes separate charged particles, or ions, inside and outside the cell. When ion movement changes the membrane’s electrical state, the neuron can produce and transmit a signal. These rapid signals allow brain cells to communicate across neural circuits.

Channelrhodopsins work by using the same basic electrical principle. They form light-controlled passages in the cell membrane. When light opens a channel, ions move through it and alter the neuron’s electrical state. This lets researchers influence a neuron’s activity by delivering light instead of relying on broader electrical stimulation.

The article emphasizes that the brain communicates on a millisecond timescale. Optogenetics can therefore control targeted neurons at a speed suited to normal neural signaling. Understanding ion-based communication also explains why light-gated channels are powerful tools. They connect an external signal, light, directly to the electrical behavior of selected cells.

Key Facts:

📌 The 2026 Nobel Prize recognized light-gated ion channels and optogenetics.

📌 Kateriya identified channelrhodopsin genes in Chlamydomonas.

📌 His research began with basic questions about how algae sense light.

📌 Optogenetics controls selected cells using light-sensitive proteins.

📌 Light changes ion movement and therefore a neuron’s electrical activity.

📌 The technique can target cells with millisecond precision.

📌 Kateriya studied light detection in the alga Chlamydomonas.